Arthritis & Rheumatology News and Research

Latest Arthritis & Rheumatology News and Research

Physical therapy associated with lower odds of long-term opioid use after total knee replacement

The world's most common form of arthritis, knee osteoarthritis, causes sufferers pain and hurts their quality of life.

27 Oct 2021

Frequency domain optical imaging could reliably identify lupus arthritis and track disease progression

Systemic lupus erythematosus (SLE), commonly referred to as simply "lupus", is an autoimmune disorder where the body's immune system attacks healthy tissue.

26 Oct 2021

New method measures temperature inside the body for detecting cancer, other diseases

Russian researchers have proposed a method for detecting cancer and other diseases by measuring the temperature inside the body. Results were published in Sensors.

25 Oct 2021

Electroceutical research with widespread implications for regulating spleen function

An international team of researchers, led by University of Houston Cullen Endowed Professor of biomedical engineering Mario Romero-Ortega, has progressed electroceutical research for treatment of diseases including rheumatoid arthritis, colitis and sepsis.

25 Oct 2021

Researchers identify mechanism behind insufficient treatment efficacy of psoriasis drugs

Interleukin-12 - a messenger molecule of immune cells - was long considered to trigger the development of psoriasis.

22 Oct 2021

Playing elite rugby may affect cognitive function in older age, study shows

Retired male elite rugby union players aged 50+ who suffered three or more rugby-related concussions during their career have no worse average cognitive function than those who had experienced no, one or two concussions, according to a new study in Alzheimer's & Dementia: The Journal of the Alzheimer's Association.

21 Oct 2021

Researchers develop a new method to remove old cells from tissues to slow down aging

No one knows why some people age worse than others and develop diseases -such as Alzheimer's, fibrosis, type 2 diabetes or some types of cancer- associated with this ageing process.

20 Oct 2021

Discovery could lead to new treatments for axial spondyloarthritis

In a paper published today in the journal Science Translational Medicine, researchers at the Schroeder Arthritis Institute, part of University Health Network in Toronto, have made a discovery that could lead to new treatments for axial spondyloarthritis (SpA), a painful and debilitating form of arthritis which affects 1-2% of Canadians and causes inflammation in the spine, joints, eyes, gut and skin.

20 Oct 2021

Scientists search for cause of mysterious covid-related inflammation in children

Like most other kids with covid, Dante and Michael DeMaino seemed to have no serious symptoms.

20 Oct 2021

Famous scientist joins NYU Langone’s Division of Rheumatology

Nationally recognized for his work studying a novel inflammatory disorder known as VEXAS, David B. Beck, MD, PhD, has joined the Division of Rheumatology at NYU Langone.

18 Oct 2021

New research focuses on better understanding of lupus in Black women

Nine out of 10 patients with systemic lupus erythematosus - the autoimmune disease also known as SLE - are females.

18 Oct 2021

NYU Langone Health opens an expansive care center in Bethpage

As part of its commitment to enhance access to high-quality care, NYU Langone Health has opened NYU Langone Ambulatory Care Bethpage—one of Nassau County's largest multispecialty care centers—at 185 Central Avenue.

15 Oct 2021

New discovery suggests potential treatment target for osteoporosis and rheumatoid arthritis

A new discovery about osteoporosis suggests a potential treatment target for that brittle-bone disease and for bone loss from rheumatoid arthritis.

14 Oct 2021

Anti-rheumatic drug as a potential candidate for treating COVID-19

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) produces inflammatory cytokine storms. But an FDA-approved anti-rheumatic drug, Auranofin, used to treat autoimmune and infectious diseases, may also help serve as an antiviral treatment for COVID-19 infection.

13 Oct 2021

Abnormal T cell responses to COVID-19 do not appear to be the cause of MIS-C in children

Multisystem inflammatory syndrome in children (MIS-C) is a serious condition associated with a recent COVID-19 infection.

7 Oct 2021

Deadly subtype of T-cell lymphoma harbors unique mutations

An especially deadly subtype of T-cell lymphoma is distinguished by unique mutations in a specific protein signaling pathway, according to a study published in the journal Blood.

7 Oct 2021

Massage can enhance healing and strength of muscles, study finds

Massage has been used to treat sore, injured muscles for more than 3,000 years, and today many athletes swear by massage guns to rehabilitate their bodies. But other than making people feel good, do these "mechanotherapies" actually improve healing after a severe injury? According to a new study from researchers at Harvard's Wyss Institute for Biologically Inspired Engineering and John A. Paulson School of Engineering and Applied Sciences (SEAS), the answer is "yes."

7 Oct 2021

Large study of COVID vaccine side effects in Sweden

Recently, researchers from Sweden reported population-based, age- and sex-specific background incidence rates of conditions that represent potential COVID-19 vaccine adverse events of special interest (AESI) in the general Swedish population with the help of registered data. This study is published on the medRxiv* preprint server.

6 Oct 2021

Elevated allostatic load may impact treatment completion and breast cancer survival outcomes

Elevated allostatic load was associated with a lower likelihood of completing chemotherapy and a lower overall survival rate in patients with lymph node-positive or high-risk lymph node-negative HER2-negative breast cancer, according to results presented at the 14th AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved, held online October 6-8, 2021.

6 Oct 2021

Autoimmune disease drug helps prevent lung damage, death in mice with SARS-CoV-2 infection

In a new paper, researchers at the University of Illinois Chicago report that a drug approved for treating patients with autoimmune disease helped to prevent lung damage and death in mice infected with the SARS-CoV-2 virus, which causes COVID-19 in humans.

6 Oct 2021

Arthritis & Rheumatology News and Research

Latest Arthritis & Rheumatology News and Research

Physical therapy associated with lower odds of long-term opioid use after total knee replacement

Frequency domain optical imaging could reliably identify lupus arthritis and track disease progression

New method measures temperature inside the body for detecting cancer, other diseases

Electroceutical research with widespread implications for regulating spleen function

Researchers identify mechanism behind insufficient treatment efficacy of psoriasis drugs

Playing elite rugby may affect cognitive function in older age, study shows

Researchers develop a new method to remove old cells from tissues to slow down aging

Discovery could lead to new treatments for axial spondyloarthritis

Scientists search for cause of mysterious covid-related inflammation in children

Famous scientist joins NYU Langone’s Division of Rheumatology

New research focuses on better understanding of lupus in Black women

NYU Langone Health opens an expansive care center in Bethpage

New discovery suggests potential treatment target for osteoporosis and rheumatoid arthritis

Anti-rheumatic drug as a potential candidate for treating COVID-19

Abnormal T cell responses to COVID-19 do not appear to be the cause of MIS-C in children

Deadly subtype of T-cell lymphoma harbors unique mutations

Massage can enhance healing and strength of muscles, study finds

Large study of COVID vaccine side effects in Sweden

Elevated allostatic load may impact treatment completion and breast cancer survival outcomes

Autoimmune disease drug helps prevent lung damage, death in mice with SARS-CoV-2 infection

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Arthritis & Rheumatology News and Research

Latest Arthritis & Rheumatology News and Research

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Newsletters you may be interested in